Literature DB >> 24814559

Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies.

Luke E Taylor1, Amy L Swerdfeger1, Guy D Eslick2.   

Abstract

There has been enormous debate regarding the possibility of a link between childhood vaccinations and the subsequent development of autism. This has in recent times become a major public health issue with vaccine preventable diseases increasing in the community due to the fear of a 'link' between vaccinations and autism. We performed a meta-analysis to summarise available evidence from case-control and cohort studies on this topic (MEDLINE, PubMed, EMBASE, Google Scholar up to April, 2014). Eligible studies assessed the relationship between vaccine administration and the subsequent development of autism or autism spectrum disorders (ASD). Two reviewers extracted data on study characteristics, methods, and outcomes. Disagreement was resolved by consensus with another author. Five cohort studies involving 1,256,407 children, and five case-control studies involving 9,920 children were included in this analysis. The cohort data revealed no relationship between vaccination and autism (OR: 0.99; 95% CI: 0.92 to 1.06) or ASD (OR: 0.91; 95% CI: 0.68 to 1.20), nor was there a relationship between autism and MMR (OR: 0.84; 95% CI: 0.70 to 1.01), or thimerosal (OR: 1.00; 95% CI: 0.77 to 1.31), or mercury (Hg) (OR: 1.00; 95% CI: 0.93 to 1.07). Similarly the case-control data found no evidence for increased risk of developing autism or ASD following MMR, Hg, or thimerosal exposure when grouped by condition (OR: 0.90, 95% CI: 0.83 to 0.98; p=0.02) or grouped by exposure type (OR: 0.85, 95% CI: 0.76 to 0.95; p=0.01). Findings of this meta-analysis suggest that vaccinations are not associated with the development of autism or autism spectrum disorder. Furthermore, the components of the vaccines (thimerosal or mercury) or multiple vaccines (MMR) are not associated with the development of autism or autism spectrum disorder.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autism; Autism spectrum disorder; Immunisation; Mercury; Thimerosal; Vaccination; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 24814559     DOI: 10.1016/j.vaccine.2014.04.085

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  90 in total

Review 1.  Advances in nonhuman primate models of autism: Integrating neuroscience and behavior.

Authors:  M D Bauman; C M Schumann
Journal:  Exp Neurol       Date:  2017-08-01       Impact factor: 5.330

Review 2.  Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.

Authors:  Stephen J Russell; Dusica Babovic-Vuksanovic; Alice Bexon; Roberto Cattaneo; David Dingli; Angela Dispenzieri; David R Deyle; Mark J Federspiel; Adele Fielding; Eva Galanis; Martha Q Lacy; Bradley C Leibovich; Minetta C Liu; Miguel Muñoz-Alía; Tanner C Miest; Julian R Molina; Sabine Mueller; Scott H Okuno; Nandakumar Packiriswamy; Tobias Peikert; Corey Raffel; Frits Van Rhee; Guy Ungerechts; Paul R Young; Yumei Zhou; Kah-Whye Peng
Journal:  Mayo Clin Proc       Date:  2019-06-22       Impact factor: 7.616

3.  Obstetrician-Gynecologists' Strategies to Address Vaccine Refusal Among Pregnant Women.

Authors:  Sean T O'Leary; Laura E Riley; Megan C Lindley; Mandy A Allison; Alison P Albert; Allison Fisher; Angela J Jiles; Lori A Crane; Laura P Hurley; Brenda Beaty; Michaela Brtnikova; Allison Kempe
Journal:  Obstet Gynecol       Date:  2019-01       Impact factor: 7.661

4.  Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States.

Authors:  Nathan C Lo; Peter J Hotez
Journal:  JAMA Pediatr       Date:  2017-09-01       Impact factor: 16.193

Review 5.  The Putative Role of Environmental Mercury in the Pathogenesis and Pathophysiology of Autism Spectrum Disorders and Subtypes.

Authors:  G Morris; B K Puri; R E Frye; M Maes
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

Review 6.  [Postvaccinal complications and management of suspected cases].

Authors:  Doris Oberle; Dirk Mentzer; Fabia Rocha; Renz Streit; Karin Weißer; Brigitte Keller-Stanislawski
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

7.  The Potential for Narrative Correctives to Combat Misinformation.

Authors:  Angeline Sangalang; Yotam Ophir; Joseph N Cappella
Journal:  J Commun       Date:  2019-04-30

8.  Launching Effectiveness Research to Guide Practice in Neurosurgery: A National Institute Neurological Disorders and Stroke Workshop Report.

Authors:  Patricia Walicke; Aviva Abosch; Anthony Asher; Fred G Barker; Zoher Ghogawala; Robert Harbaugh; Lara Jehi; John Kestle; Walter Koroshetz; Roderick Little; Donald Rubin; Alex Valadka; Stephen Wisniewski; E Antonio Chiocca
Journal:  Neurosurgery       Date:  2017-04-01       Impact factor: 4.654

9.  Perspectives in Primary Care: Disseminating Scientific Findings in an Era of Fake News and Science Denial.

Authors:  Arch G Mainous
Journal:  Ann Fam Med       Date:  2018-11       Impact factor: 5.166

10.  Vaccination Rates among Younger Siblings of Children with Autism.

Authors:  Gena Glickman; Elizabeth Harrison; Karen Dobkins
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.